Global Antibodies Industry is projected to reach $ 161.897 Billion by 2021 with a CAGR of 11.20%

17/ago/2017 09:32:19 MDFtends Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

According to the report Global Antibodies Industry, published by Market Data Forecast, The Global Industry was worth $ 95.217 Billion in 2016 and estimated to reach $ 161.897 Billion by the end of 2021 with a growing potential of 11.20 %.

Antibodies are proteins that are produced in response to specific antigens by plasma cells. They are also called as immunoglobulin. These antibodies are used as diagnostics as well as Therapeutic purposes for several indications of diseases, including but not limited to, rheumatoid arthritis, non-Hodgkin lymphoma, psoriasis, Crohn’s disease, macular degeneration, hypercholesterolemia, and asthma. Owing to a number of product launches, antibodies Industry is projected to witness steady growth. Effective harmonisation of product development, approval and registration guidelines in some of the major Industrys, such as United States and European Union can speed up the research and development of antibody related products.

Browse Industry data tables and in-depth TOC of the Global Antibodies Industry to 2021 @

Major factors that are primarily driving the Global antibodies Industry are continuous development of innovative products, increased adoption rate to therapeutic antibodies in cost-sensitive Industrys, rise in chronic illnesses owing to population shift and increasing longevity, swift approval by regulatory authorities for breakthrough therapies, and adoption of diagnostic antibodies. Companies are adopting to various strategies, like expansion of products indications to sustain the dynamically growing Industry. High cost of treatment and side effects associated with antibodies treatment can hamper the growth of global antibodies Industry.

Based on product type, the Industry is segmented into Monoclonal Antibodies, Polyclonal Antibodies, and Anti-body drug complexes. The monoclonal antibodies are further segmented into Murine, Chimeric, Humanized, and Human. The polyclonal antibodies are further categorized into Type I, Type II, Type III, Type IV, Type V, Type VI, Type VII, Type VIII. The Antibody-Drug Complexes are further segmented into Immunogen Technology, Seattle Genetics Technology, and Immunomedics Technology. Monoclonal antibodies segment accounts for the highest Industry share in the Industry.

Free sample of the report is available @

Based on Indication, the Industry is segmented into Cancer, Auto immune diseases, Infectious diseases, cardiovascular diseases, and CNS disorders, others (Inflammatory, Microbial Diseases, & Other). Based on end users, the Industry is segmented into Hospitals/Clinics, Research institute, Diagnostics laboratories. Cancer indication type segment is predicted to account highest Industry share over the forecast period due to broad range applications of monoclonal antibodies for the treatment of various cancers.

Based on Application, the Industry is segmented into Medical, Experimental. The Experimental segment is further categorized into Western blot, ELISA, Radioimmune Assays, immunofluorescence, others (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry). Hospitals is predicted to account the highest share in global antibodies Industry during the forecast period.

Inquire before buying @

Based on Geography, the Antibodies Industry is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

Some of the major companies operating in global Antibodies Industry are Abbott Diagnostics, Novartis AG, Pfizer Inc., ThermoFisher Scientific Inc., Eli Lilly and company, A.G. Scientific, Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., AbbVie Inc.

Key Points from Table of Contents


  • Executive Summary
  • Key Inferences
  • New Developments

Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

Industry Segmentation

  • By Product Type
  • By Indication
  • End User
  • Application

Geographical Analysis

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Strategic Analysis

  • PESTLE analysis
  • Porter’s Five analysis

Industry Leaders' Analysis

Competitive Landscape

Avail discount @

About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.


Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206


Visit MarketDataForecast Blog @

View latest Press Releases of MDF @


blog comments powered by Disqus è un servizio offerto da Factotum Srl